TOPLINE: Increased emergency department (ED) boarding duration directly increases the risk for delirium or severe agitation during inpatient admission, especially among patients with dementia. METHODOLOGY: To […]

TOPLINE: In patients with type 2 diabetes (T2D) on first-line glucagon-like peptide 1 (GLP-1) receptor agonist therapy, adding or switching to second-generation basal insulins (2BI) may […]

TOPLINE:  The combination of selective intracameral antibiotics with 1% povidone iodine for disinfection can be as effective as the standard practice of using 5% povidone iodine […]

TOPLINE: In men with type 2 diabetes (T2D), higher serum levels of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) were associated with a lower risk for […]

TOPLINE: A small pool of major surgeries accounts for a large portion of opioids prescribed to children and teens, according to a new study published in […]

TOPLINE: In people with type 2 diabetes (T2D), tirzepatide raised the odds of achieving normoglycaemia by more than 16-fold. METHODOLOGY: Data were pooled from nine phase […]

TOPLINE: A study on lampalizumab injections for patients with geographic atrophy found the drug to be associated with a low risk for persistent alterations in intraocular […]

TOPLINE: Treatment of patients with active psoriatic arthritis with sonelokimab — an interleukin (IL)-17A- and IL-17F-inhibiting nanobody — led to a higher percentage of patients with […]

TOPLINE: An experimental pancreatic gene therapy given to a mouse model of obesity as a one-time, single-dose treatment showed improvements in body composition and fasting glucose […]